Breakthrough Compound LY2444296 Shows Promise in Treating Alcohol Use Disorder, According to Study
Breakthrough Compound Shows Promise in Treating Alcohol Use Disorder Key Facts: LY2444296 targets the kappa opioid receptor, showing potential to reduce alcohol consumption in rats with alcohol dependence without affecting non-dependent rats. The compound successfully decreased withdrawal symptoms and alcohol intake after just 8 hours of abstinence, a critical period for withdrawal onset. Funded by … Read more